Kolexia
Kalish Michal Médecine générale
Kalish Michal
Médecine générale
Centre Paul Strauss
Strasbourg, France
30 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Fatigue Carcinome épidermoïde Carcinomes COVID-19 Carcinome épidermoïde de la tête et du cou Tumeurs du côlon Cachexie Carcinome pulmonaire non à petites cellules

Collaborateurs

Voir plus
Fischbach Cathie
Fischbach Cathie
Centre Paul Strauss, Strasbourg, France
Petit Thierry
Petit Thierry
Centre Paul Strauss, Strasbourg, France
Pivot Xavier
Pivot Xavier
Centre Paul Strauss, Strasbourg, France
Pierard Laure
Pierard Laure
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
A+A
4 collaboration(s)
Dernière en 2021
MundiPharma
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2023
Amgen
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.
Journal of cachexia, sarcopenia and muscle   06 janvier 2024
Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.
Cancer treatment and research communications   25 juin 2023
A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.
Breast cancer research and treatment   23 décembre 2022
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
Cancer   17 novembre 2022
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Clinical breast cancer   13 octobre 2022
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients.
Journal of cachexia, sarcopenia and muscle   04 avril 2022
Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak
2021 San Antonio Breast Cancer Symposium   15 février 2022
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Frontiers in oncology   27 octobre 2021
286P Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
319P A propensity score weighted study comparing two versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021